Factors associated with the development of renal complications of diabetes mellitus in São Paulo city

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 6, 1997, Pages 735-744

  Ferreira, S R G ^a   Pinto, F M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Associated factors; Chronic renal failure; Diabetes mellitus; Diabetic nephropathy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CASE CONTROL STUDY; CHILD; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FEMALE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BRAZIL; CASE-CONTROL STUDIES; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0031159714     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-879X1997000600006     Document Type: Article

References (51)

1. Richard PD & Trevor JO (1992). Diabetes mellitus and macrovascular complications - An epidemiological perspective. Diabetes Care, 15: 1141-1155.
2. Borch-Johnsen K, Krag-Andersen P & Deckert T (1985). The effect of proteinuria on relative mortality in type I (insulin-dependent) diabetes mellitus. Diabetologia, 28: 590-596.
3. Mogensen CE (1984). Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. New England Journal of Medicine, 310: 356-360.
4. Mattock MB, Morrish NH, Viberti GC, Keen H, Fitzgerald A & Jackson G (1992). Prospective study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes, 41: 736-741.
5. Alzaid AA (1996). Microalbuminuria in patients with NIDDM: An overview. Diabetes Care, 19: 79-84.
6. Malerbi DA & Franco U (1992). Multicenter study of the prevalence of diabetes mellitus and impaired glucose tolerance in the urban Brazilian population aged 30-69 yr. Diabetes Care, 15: 1509-1516.
7. Ferreira SRG, Franco LJ, Vivolo MA, Negrato CA, Simōes ACP & Ventureli CR (1993). Population-based incidence of IDDM in the State of São Paulo - Brazil. Diabetes Care, 16: 701-704.
8. Bingley PJ & Gale EAM (1989). Raising incidence of IDDM in Europe. Diabetes Care, 12: 289-295.
9. Diabetes Epidemiology Research International Group (1990). Secular trends in incidence of childhood IDDM in 10 countries. Diabetes, 39: 858-864.
10. Andersen AR, Sandahl CJ & Andersen JK (1983). Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia, 25: 496-501.
11. Fabre J, Balant LP, Fox HM & Vernet AT (1982). The kidney in maturity onset diabetes mellitus: a clinical study of 50 patients. Kidney International, 21: 730-738.
12. Humphrey LL, Ballard DJ & Frohneid PP (1989). Chronic renal failure in non-insulin dependent diabetes mellitus: a population-based study in Rochester, Minnesota. Annals of Internal Medicine, 111: 788-796.
13. Nelson RG, Newman JN, Knowler WC, Suvers ML, Kunzelman CL & Pettit DJ (1988). Incidence of end-stage renal disease in type 2 (non-insulin dependent) diabetes mellitus in Pima Indians. Diabetologia, 31: 730-736.
14. Markell MS & Friedman EA (1992). Diabetic nephropathy: management of endstage patients. Diabetes Care, 15: 1226-1236.
15. USRDS Annual Data Report (1991). Incidence and causes of treated ESRD. American Journal of Kidney Diseases, 18 (Suppl 2): 21-29.
16. Report on Management of Renal Failure in Europe, XXIII (1991). Nephrology Dialysis Transplantation, 7: 5-48.
17. Registro Latino Americano de Dialise y Transplante Renal - Informe de Diélise Ano 1991 - Sociedad Latinoamericana de Nefrologia - maio de 1993.
18. Pugh JA, Medina R & Ramirez M (1993). Comparison of the course to end-stage renal disease of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic nephropathy. Diabetologia, 36: 1094-1098.
19. Stephens GW, Gillaspy JA, Clyne D, Mejia A & Pollak VE (1990). Racial differences in the incidence of end-stage renal disease in type I and II diabetes mellitus. American Journal of Kidney Diseases, 15: 562-567.
20. Pirat J (1978). Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care, 1: 168-188.
21. Coonroad BA, Ellis D, Becker D & Bunker C (1993). Predictor of microalbuminuria in individuals with IDDM. Pittsburg Complications Study. Diabetes Care, 16: 1376-1383.
22. Krolewski AS, Canessa M, Warran JH, Laffel LMB, Christlieb R, Knowler WC & Rand LI (1988). Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. New England Journal of Medicine, 318: 140-145.
23. Krolewski AS (1989). The natural history of diabetic nephropathy in type 1 diabetes and the role of hypertension. Annals of Internal Medicine, 110: 795-798.
24. Sawicki PT, Didjurgut V, Muhlauser I & Bender R (1994). Smoking is associated with progression of diabetic nephropathy. Diabetes Care, 17: 126-131.
25. Retting B & Teutsch SM (1984). The incidence of end-stage renal disease in type I and type II diabetes mellitus. Diabetic Nephropathy, 3: 26-27.
26. Grenfell A, Bewick M, Parsons V, Snowden S, Taubre D & Watkins PJ (1988). Non-insulin dependent diabetes and renal replacement therapy. Diabetic Medicine, 5: 172-176.
27. West KM, Edreich LJ & Stober JA(1980). A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes, 29: 501-508.
28. Gross JL, Stein ACR, Beck MO, Fuchs SC, Silverio SP, Azevedo MJ & Friedman R (1993). Risk factors for the development of proteinuria by type II (non-insulin dependent) diabetic patients. Brazilian Journal of Medical and Biological Research, 26: 1269-1278.
29. V Registro Brasileiro de Diélise e Transplante Renal (1993). In: XVII Congresso Brasileiro de Nefrologia da Sociedade Brasileira de Nefrologia, Fortaleza, 1994.
30. Sesso R, Anção MS, Madeira SA & Comissāo Regional de Nefrologia da Secretaria da Saúde de São Paulo e Centro de Informática da Escola Paulista de Medicina (1991). Aspectos epidemiológicos do tratamento dialitico na Grande São Paulo. Revista da Associação Médica Brasileira, 40: 10-14.
31. Marconi JT (1959). The concept of alcoholism. Quarterly Journal of Studies on Alcohol, 20: 216-235.
32. Pugh JA (1989). The epidemiology of diabetic nephropathy. Diabetes and Metabolism Reviews, 5: 531-546.
33. Fundação IBGE (1992). IX Recenseamento Geral do Brasil - 1980. Rio de Janeiro, Vol. 1, Tomo 4, 10-11.
34. Pao CI, Whittle JC, Whelton PK & Sudler AJ (1992). The excess incidence of diabetic end-stage renal disease among blacks: a population-based study of potential explanatory factors. JAMA, 268: 3079-3084.
35. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP & Hawthorme VM (1989). Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. New England Journal of Medicine, 321: 1074-1079.
36. Cowie CC, Port FK, Rust KF & Harris MI (19941. Differences in survival between black and white patients with diabetic end-stage renal disease. Diabetes Care, 17: 681-687.
37. Kostraba NJ, Dorman JS, Ochard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE & Drash AL (1989). Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care, 12: 686-693.
38. Krolewski AS, Warran JH, Christlieb AR, Busick EJ & Kahn CR (1985). The changing natural history of nephropathy in type 1 diabetes. American Journal of Medicine, 78: 785-794.
39. Diabetes Control and Complications Trial (DCCT) Research Group (1995). Effect of intensive therapy on the development and progression of diabetic nephropathy in diabetes control and complications trial. Kidney International, 47: 1703-1720.
40. Spallone V, Gambardella S, Maiello MR, Barini A, Frontoni S & Menzinger G (1994). Relationship between autonomic neuropathy, 24-h blood pressure profile and nephropathy in normotensive IDDM patients. Diabetes Care, 17: 578-584.
41. Christlieb AR, Warram JH, Krolewski AS, Busick EJ, Ganda OP & Asmal AC (1981). Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes, 30 (Suppl 2): 90-96.
42. Mogensen CE, Hansen KW, Osterby R & Damsgaard E (1992). Blood pressure elevation versus abnormal albuminuria in the genesis and prediction of renal disease in diabetes. Diabetes Care, 15:1192-1204.
43. Marshal SM & Alberti KGMM (1989). Comparison of the prevalence and associate features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. Quarterly Journal of Medicine. 261: 61-71.
44. Parving HH & Hommel E (1989). Prognosis in diabetic nephropathy. British Medical Jounal, 299: 230-233.
45. Hasslacher C, Borgholte G, Ritz E & Wahl P (1989). Impact of hypertension on prognosis of IDDM. Diabetes and Metabolism, 15: 338-342.
46. Hosteller TH, Hennke HG & Brenner BM (1981). Intrarenal hypertension in the initiation and progression of diabetic and olher glomerulopathies. American Journal of Medicine, 72: 375-386.
47. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE & Hamman RE (1991). Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA, 265: 614-617.
48. Coper JJ, Staples AJ, Coccolone R, Nairn J, Badcock N & Henning P (1994). Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabetic Medicine, 11: 666-669.
49. Viberti GC, Yip-Messent J & Morocutti A (1992). Diabetic nephropathy: Future avenue. Diabetes Care, 15: 1216-1225.
50. Claster JA & Wood AJJ (1988). Pharmacologic aspects of cigarette smoking and nicotine addiction. New England Journal of Medicine. 319: 1318-1330.
51. Carney RM & Goldberg AP (1984). Weight gain after cessation of cigarette smoking: a possible role for adipose-tissue lipoprotein lipase. New England Journal of Medicine. 310: 614-616.